---
title: "Deutsche Bank  Sticks to Its Hold Rating for AbbVie (ABBV)"
description: "Shin covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Gilead Sciences, and AbbVie. According to TipRanks, Shin has an average return of -9.6% and a 40.00% success rate on recom"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/257398978.md"
published_at: "2025-09-15T14:35:25.000Z"
---

# Deutsche Bank  Sticks to Its Hold Rating for AbbVie (ABBV)

> Shin covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Gilead Sciences, and AbbVie. According to TipRanks, Shin has an average return of -9.6% and a 40.00% success rate on recommended stocks. In addition to Deutsche Bank , AbbVie also received a Hold from TR | OpenAI – 4o’s Veda Pharmyne in a report issued on September 9. However, today, Cantor Fitzgerald maintained a Buy rating on AbbVie (NYSE: ABBV).

Shin covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Gilead Sciences, and AbbVie. According to TipRanks, Shin has an average return of \-9.6% and a 40.00% success rate on recommended stocks.

In addition to Deutsche Bank , AbbVie also received a Hold from TR | OpenAI – 4o’s Veda Pharmyne in a report issued on September 9. However, today, Cantor Fitzgerald maintained a Buy rating on AbbVie (NYSE: ABBV).

### Related Stocks

- [ABBV.US - Abbvie](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 在艾伯維（ABBV）經歷了多年強勁的股價上漲後，現在是否已經太晚考慮投資？ | 這篇文章討論了在艾伯維（AbbVie，股票代碼：ABBV）股價大幅上漲後，它是否仍然是一個好的投資。目前股價為 231.50 美元，艾伯維在多個時期表現出強勁的回報。折現現金流（DCF）分析表明，該股票被低估了 37.8%，而市盈率（P/E | [Link](https://longbridge.com/en/news/275979716.md) |
| 艾伯維預計 2026 年調整後的每股收益將在 14.37 美元至 14.57 美元之間，而 FactSet 的預估為 14.27 美元 | (ABBV) 艾伯維預計 2026 年調整後每股收益範圍為 14.37 美元至 14.57 美元，而 FactSet 的預期為 14.27 美元 | [Link](https://longbridge.com/en/news/274820805.md) |
| Investment Partners LTD. 出售了 13,247 股艾伯維公司（AbbVie Inc.）的股票 $ABBV | Investment Partners LTD. 大幅減少了在艾伯維（AbbVie Inc.）的持股比例，下降了 76.6%，在第三季度出售了 13,247 股，剩餘 4,057 股，估值約為 939,000 美元。其他機構投資者，包括先鋒 | [Link](https://longbridge.com/en/news/276005198.md) |
| SVB Wealth LLC 出售了艾伯維公司 $ABBV 的股票 | SVB Wealth LLC 在第三季度減少了對艾伯維（AbbVie Inc.，紐約證券交易所代碼：ABBV）8.3% 的持股，目前持有 93,857 股，價值 2173 萬美元。其他投資者如 Brighton Jones LLC 和 Re | [Link](https://longbridge.com/en/news/275436633.md) |
| 微軟尋求在 AI 領域從 OpenAI 獲得更大的獨立性 | 微軟正在努力減少對 OpenAI 的依賴，開發自己的人工智能模型，目標是在 2025 年前實現自給自足。儘管對 OpenAI 進行了 130 億美元的投資，微軟仍在構建自己的系統和數據庫。該公司計劃在人工智能基礎設施上投資 1400 億美元 | [Link](https://longbridge.com/en/news/275781856.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.